{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:09:27Z","timestamp":1788235767140,"version":"build-2803163510"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1319-2442.279963","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T07:28:48Z","timestamp":1583220528000},"page":"70","source":"Crossref","is-referenced-by-count":6,"title":["Aldosterone renin ratio and chronic kidney disease"],"prefix":"10.4103","volume":"31","author":[{"given":"Issa","family":"Al Salmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wessam","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayam","family":"Al Dohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al Shaima","family":"Al Hinai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suad","family":"Hannawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FaissalA","family":"M. Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-2442.279963-1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004872-200401000-00003","article-title":"Worldwide prevalence of hypertension: A systematic review","author":"Kearney","year":"2004","journal-title":"J Hypertens"},{"key":"key-10.4103\/1319-2442.279963-2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1017\/S1368980007000183","article-title":"Body mass index, waist circumference and waist-to-hip ratio cutoff points for categorisation of obesity among Omani Arabs","author":"Al-Lawati","year":"2008","journal-title":"Public Health Nutr"},{"key":"key-10.4103\/1319-2442.279963-3","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2337\/diacare.26.6.1781","article-title":"Prevalence of the metabolic syndrome among Omani adults","author":"Al-Lawati","year":"2003","journal-title":"Diabetes Care"},{"key":"key-10.4103\/1319-2442.279963-4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/01.hjh.0000170395.93859.50","article-title":"The prevalence of hypertension in Persian Gulf countries and its correlation with demographic and socio-economic factors","author":"Al-Said","year":"2005","journal-title":"J Hypertens"},{"key":"key-10.4103\/1319-2442.279963-5","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.4103\/1319-2442.194886","article-title":"Cardiovascular and cerebrovascular comor- bidities in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcome and practice pattern study phase 5 (2012-2015)","author":"Shaheen","year":"2016","journal-title":"Saudi J Kidney Dis Transpl","ISSN":"https:\/\/id.crossref.org\/issn\/1319-2442","issn-type":"print"},{"key":"key-10.4103\/1319-2442.279963-6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: Analysis of worldwide data","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"key-10.4103\/1319-2442.279963-7","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1097\/01.ASN.0000070142.14843.8E","article-title":"Prevention of hypertension and its complications: Theoretical basis and guidelines for treatment","author":"Flack","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.279963-8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000441684","article-title":"Mineral Metabolites, Angiotensin II Inhibition and Outcomes in Advanced Chronic Kidney Disease","author":"Jovanovich","year":"2015","journal-title":"Am J Nephrol"},{"key":"key-10.4103\/1319-2442.279963-9","first-page":"432","article-title":"Effect of renin-angiotensin- aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease","author":"Spatz","year":"2012","journal-title":"Iran J Kidney Dis"},{"key":"key-10.4103\/1319-2442.279963-10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2265.2010.03832.x","article-title":"The effect of spironolactone upon cortico- steroid hormone metabolism in patients with early stage chronic kidney disease","author":"Hammer","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1319-2442.279963-11","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s11255-018-1887-9","article-title":"Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: Identification of risk factors for decreased kidney function","author":"Kim","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"key-10.4103\/1319-2442.279963-12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00467-016-3512-4","article-title":"Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD","author":"Abraham","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/1319-2442.279963-13","doi-asserted-by":"crossref","unstructured":"Gant CM, Laverman GD, Vogt L, et al. Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels. BMC Nephrol 2017;18:370..","DOI":"10.1186\/s12882-017-0789-x"},{"key":"key-10.4103\/1319-2442.279963-14","first-page":"593","article-title":"Declining prevalence of coronary artery disease in incident dialysis patients over the past two decades","author":"Iwasaki","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"key-10.4103\/1319-2442.279963-15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.echo.2015.11.019","article-title":"Independent echocardiographic markers of cardiovascular involvement in chronic kidney disease: The value of left atrial function and volume","author":"Kadappu","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"key-10.4103\/1319-2442.279963-16","first-page":"255","article-title":"Multi- centre randomized controlled trial of angio- tensin-converting enzyme inhibitor\/angiotensin receptor blocker withdrawal in advanced renal disease: The STOP-ACEi trial","author":"Bhandari","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.279963-17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/1470320315592565","article-title":"Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney disease","author":"Ikeda","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"key-10.4103\/1319-2442.279963-18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ajh.2011.245","article-title":"Mineralocorticoid receptor- associated hypertension and its organ damage: Clinical relevance for resistant hypertension","author":"Shibata","year":"2012","journal-title":"Am J Hypertens"},{"key":"key-10.4103\/1319-2442.279963-19","doi-asserted-by":"crossref","unstructured":"Khan UA, Garg AX, Parikh CR, Coca SG. Prevention of chronic kidney disease and subsequent effect on mortality: A systematic review and meta-analysis. PLoS One 2013;8: e71784..","DOI":"10.1371\/journal.pone.0071784"},{"key":"key-10.4103\/1319-2442.279963-20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.114.03311","article-title":"Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: Findings from the chronic renal insufficiency cohort (CRIC) Study","author":"Deo","year":"2014","journal-title":"Hypertension"},{"key":"key-10.4103\/1319-2442.279963-21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ehf2.12227","article-title":"Amount or intensity.Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction?","author":"Bobenko","year":"2018","journal-title":"ESC Heart Fail"},{"key":"key-10.4103\/1319-2442.279963-22","first-page":"241","article-title":"Differences in hypertension between blacks and whites: An overview","author":"Lindhorst","year":"2007","journal-title":"Cardiovasc J Afr"},{"key":"key-10.4103\/1319-2442.279963-23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.mcna.2009.02.014","article-title":"The renin angiotensin aldosterone system in hypertension: Roles of insulin resistance and oxidative stress","author":"Manrique","year":"2009","journal-title":"Med Clin North Am"},{"key":"key-10.4103\/1319-2442.279963-24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1524-6175.2005.04617.x","article-title":"Hypertension and the cardiometa- bolic syndrome","author":"Manrique","year":"2005","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"key-10.4103\/1319-2442.279963-25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneph.2013.251","article-title":"The effect of RAAS blockade on the progression of diabetic nephropathy","author":"Roscioni","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"key-10.4103\/1319-2442.279963-26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.113.02217","article-title":"Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity","author":"Nguyen","year":"2014","journal-title":"Hypertension"},{"key":"key-10.4103\/1319-2442.279963-27","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ki.2009.9","article-title":"Aldos- terone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt","author":"Lea","year":"2009","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.279963-28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MNH.0000000000000051","article-title":"Is there a new dawn for selective mineralocorticoid receptor antagonism?","author":"Luther","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key-10.4103\/1319-2442.279963-29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MNH.0000000000000189","article-title":"Aldosterone in vascular and metabolic dysfunction","author":"Luther","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key-10.4103\/1319-2442.279963-30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.2012.170","article-title":"Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury","author":"Luther","year":"2012","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.279963-31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1681\/ASN.2014111137","article-title":"Activation of the endogenous renin-angiotensin-aldosterone system or aldosterone administration increases urinary exosomal sodium channel excretion","author":"Qi","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.279963-32","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1097\/HJH.0b013e328354f65b","article-title":"Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: The Ohasama Study","author":"Terata","year":"2012","journal-title":"J Hypertens"},{"key":"key-10.4103\/1319-2442.279963-33","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2010010085","article-title":"A multi- marker approach to predict incident CKD and microalbuminuria","author":"Fox","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.279963-34","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.105.539122","article-title":"Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria","author":"Quinkler","year":"2005","journal-title":"Circulation"},{"key":"key-10.4103\/1319-2442.279963-35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12882-016-0337-0","article-title":"Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: A systematic review and meta- analysis","author":"Currie","year":"2016","journal-title":"BMC Nephrol"},{"key":"key-10.4103\/1319-2442.279963-36","doi-asserted-by":"crossref","first-page":"c217","DOI":"10.1159\/000321687","article-title":"Proteinuria thresholds are irrational: A call for proteinuria indexing","author":"Ellam","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"key-10.4103\/1319-2442.279963-37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2012.10.549","article-title":"Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo","author":"Queisser","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"key-10.4103\/1319-2442.279963-38","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0029-1243253","article-title":"Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists","author":"Schupp","year":"2010","journal-title":"Horm Metab Res"},{"key":"key-10.4103\/1319-2442.279963-39","first-page":"6403985","article-title":"End-stage kidney failure in Oman: An analysis of registry data with an emphasis on congenital and inherited renal diseases","author":"Al","year":"2017","journal-title":"Int J Nephrol"},{"key":"key-10.4103\/1319-2442.279963-40","first-page":"263","article-title":"Kidney Disease in Oman: A View of the Current and Future Landscapes","author":"Al","year":"2017","journal-title":"Iran J Kidney Dis"},{"key":"key-10.4103\/1319-2442.279963-41","first-page":"27","article-title":"Epidemiological transition of end-stage kidney disease in Oman","author":"Al","year":"2017","journal-title":"Kidney Int Rep"},{"key":"key-10.4103\/1319-2442.279963-42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1681\/ASN.2007050531","article-title":"Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium","author":"Terada","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.279963-43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10157-011-0498-x","article-title":"Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serumand glucocorticoid-inducible protein kinase-1","author":"Terada","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"key-10.4103\/1319-2442.279963-44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2008.12.008","article-title":"Glucocorticoid receptor plays an indispensable role in mineralocorticoid receptor-dependent transcription in GR-deficient BE(2)C and T84 cells in vitro","author":"Tsugita","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"key-10.4103\/1319-2442.279963-45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2012.06597.x","article-title":"Visceral adipose tissue: Emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations","author":"Boscaro","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/1319-2442.279963-46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/157016112799304969","article-title":"Aldosterone, mine- ralocorticoid receptor and the metabolic syndrome: Role of the mineralocorticoid receptor antagonists","author":"Ronconi","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"key-10.4103\/1319-2442.279963-47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tem.2005.02.010","article-title":"Aldosterone as a cardiovascular risk factor","author":"Rossi","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"key-10.4103\/1319-2442.279963-48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1559-4564.2007.06663.x","article-title":"Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: The diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial","author":"McFarlane","year":"2007","journal-title":"J Cardiometab Syndr"},{"key":"key-10.4103\/1319-2442.279963-49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12967-017-1319-0","article-title":"The effect of renal denervation in an experimental model of chronic renal insufficiency, The REmnant kidney Denervation In Pigs study (REDIP study)","author":"Lubanda","year":"2017","journal-title":"J Transl Med"},{"key":"key-10.4103\/1319-2442.279963-50","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ki.2011.505","article-title":"Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: Current concepts and emerging treatment paradigms","author":"Shavit","year":"2012","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.279963-51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.5414\/CN106973","article-title":"Effect of eplerenone on blood pressure and the renin-angiotensin-aldosterone system in oligo- anuric chronic hemodialysis patients a pilot study","author":"Shavit","year":"2011","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/1319-2442.279963-52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5414\/CN109236","article-title":"Preoperative aldosterone receptor blockade and outcomes of cardiac surgery in patients with chronic kidney disease","author":"Shavit","year":"2018","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/1319-2442.279963-53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.ajkd.2016.04.011","article-title":"The safety and efficacy of mineralocorticoid receptor antagonists in patients who require dialysis: A systematic review and meta- analysis","author":"Quach","year":"2016","journal-title":"Am J Kidney Dis"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:42:41Z","timestamp":1786732961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.279963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"alternative-id":["279963"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.279963","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}